Moderna mRNA Flu Vaccine Clears FDA Hurdle, Decision Set for August
Moderna's mRNA flu vaccine mRNA-1010 wins FDA review after initial rejection, with a decision date of August 5, 2026 for potential approval.
Education press releases from universities, schools, EdTech companies, and research institutions.
142 press releases found
Moderna's mRNA flu vaccine mRNA-1010 wins FDA review after initial rejection, with a decision date of August 5, 2026 for potential approval.
Eli Lilly's retatrutide triple agonist achieves 28.7% weight loss in TRIUMPH-4 trial, matching bariatric surgery outcomes and reshaping obesity treatment.